Stay updated on Galunisertib with Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the usual study record content. The study description, documents, and location information are no longer accessible on that page.SummaryDifference20%

- Check16 days agoChange DetectedThe page revision tag was updated from v3.6.6 to v3.7.0. This indicates a new version of the page content has been released.SummaryDifference0.0%

- Check30 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6, indicating a page version update; the change appears to affect only the revision label and not the study content or core functionality.SummaryDifference0.0%

- Check37 days agoChange DetectedA new NIH grant/contract tag was added to the study's identifiers, indicating NIH funding support for this trial. This addition helps identify the source of funding in the study metadata.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page’s revision tag was updated to v3.6.5 from v3.6.4, indicating a small template update rather than a change to study information or user actions.SummaryDifference0.0%

- Check72 days agoChange DetectedA new revision tag v3.6.4 appears on the page, replacing the previous v3.6.3 to reflect a minor site update.SummaryDifference0.0%

Stay in the know with updates to Galunisertib with Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page.